BriaCell Therapeutics Corp.(BCTX),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

BCTX BriaCell Therapeutics Corp.

Post-Mkt 05-20 19:04:21 EDT

3.88

+0.37

+10.54%

盘后3.88

+0.00-0.03%

18:40 EDT

High3.97	Low3.40	Vol472.03K
Open3.53	D1 Closing3.51	Amplitude16.22%
Mkt Cap28.13M	Tradable Cap25.15M	Total Shares7.25M
T/O1.79M	T/O Rate7.28%	Tradable Shares6.48M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"BCTX","market":"US","secType":"STK","nameCN":"BriaCell Therapeutics Corp.","latestPrice":3.88,"timestamp":1779307200000,"preClose":3.51,"halted":0,"volume":472032,"hourTrading":{"tag":"盘后","latestPrice":3.8787,"preClose":3.88,"latestTime":"18:40 EDT","volume":35,"amount":135.0105015,"timestamp":1779316842810,"change":-0.0013,"changeRate":-0.000335,"amplitude":0.018041},"delay":0,"changeRate":0.10541310541310545,"floatShares":6482500,"shares":7250500,"eps":-19.979195,"marketStatus":"Post-Mkt","change":0.37,"latestTime":"05-20 19:04:21 EDT","open":3.53,"high":3.97,"low":3.4007,"amount":1788163.2815903998,"amplitude":0.162194,"askPrice":3.96,"askSize":200,"bidPrice":3.65,"bidSize":50,"shortable":3,"etf":0,"ttmEps":-19.979195,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1779321600000},"marketStatusCode":4,"adr":0,"listingDate":1614142800000,"exchange":"NASDAQ","adjPreClose":3.51,"preHourTrading":{"tag":"盘前","latestPrice":3.5,"preClose":3.51,"latestTime":"09:29 EDT","volume":1837,"amount":6552.8297505,"timestamp":1779283780892,"change":-0.01,"changeRate":-0.002849,"amplitude":0.062934},"postHourTrading":{"tag":"盘后","latestPrice":3.8787,"preClose":3.88,"latestTime":"18:40 EDT","volume":35,"amount":135.0105015,"timestamp":1779316842810,"change":-0.0013,"changeRate":-0.000335,"amplitude":0.018041},"volumeRatio":0.910845,"impliedVol":0.6056,"impliedVolPercentile":0},"requestUrl":"/m/hq/s/BCTX/wiki","defaultTab":"wiki","newsList":[{"id":"2635089191","title":"BriaCell Expands Pipeline to Include an Ovarian Cancer Immunotherapy Candidate, Bria-OVA+™","url":"https://stock-news.laohu8.com/highlight/detail?id=2635089191","media":"GlobeNewswire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635089191?lang=en_us&edition=fundamental","pubTime":"2026-05-15 19:30","pubTimestamp":1778844600,"startTime":"0","endTime":"0","summary":"BriaCell expands push in women’s health, building on Phase 2 success in advanced metastatic breast cancerBria-OVA+, BriaCell’s next generation personalized immunotherapy candidate for ovarian cancer, ","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/05/15/3295754/0/en/BriaCell-Expands-Pipeline-to-Include-an-Ovarian-Cancer-Immunotherapy-Candidate-Bria-OVA.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ATCC","BCTX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635714106","title":"BriaCell Completes Manufacturing of Clinical Supplies of Bria-PROS+™ for Prostate Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2635714106","media":"GlobeNewswire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635714106?lang=en_us&edition=fundamental","pubTime":"2026-05-14 19:30","pubTimestamp":1778758200,"startTime":"0","endTime":"0","summary":"Bria-PROS+ is BriaCell’s next generation personalized off-the-shelf immunotherapy for prostate cancerImmune stimulating components of Bria-PROS+ enhance anti-tumor responsesBriaCell has completed manu","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/05/14/3294795/0/en/BriaCell-Completes-Manufacturing-of-Clinical-Supplies-of-Bria-PROS-for-Prostate-Cancer.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IND","BCTX","PROS","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635789046","title":"BriaCell Adds Penn Medicine’s Abramson Cancer Center as Clinical Site in Pivotal Phase 3 Breast Cancer Study","url":"https://stock-news.laohu8.com/highlight/detail?id=2635789046","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635789046?lang=en_us&edition=fundamental","pubTime":"2026-05-13 19:30","pubTimestamp":1778671800,"startTime":"0","endTime":"0","summary":"Other recently activated sites include Indiana University Melvin and Bren Simon Comprehensive Cancer Center, University of Virginia (UVA) Comprehensive Cancer Center, Baptist Health South Florida, and","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/05/13/3293887/0/en/BriaCell-Adds-Penn-Medicine-s-Abramson-Cancer-Center-as-Clinical-Site-in-Pivotal-Phase-3-Breast-Cancer-Study.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BCTX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634216305","title":"BriaCell Phase 3 Bria-IMT™ Study Enrollment Surpasses 230 Patients","url":"https://stock-news.laohu8.com/highlight/detail?id=2634216305","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634216305?lang=en_us&edition=fundamental","pubTime":"2026-05-12 19:30","pubTimestamp":1778585400,"startTime":"0","endTime":"0","summary":"Over 315 patients screened and over 230 patients enrolled in BriaCell’s pivotal Phase 3 Bria-ABC study of Bria-IMT plus immune checkpoint inhibitor in metastatic breast cancerEnrollment momentum conti","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/05/12/3292721/0/en/BriaCell-Phase-3-Bria-IMT-Study-Enrollment-Surpasses-230-Patients.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BCTX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633809051","title":"BriaCell Receives FDA Clearance to Initiate Bria-BRES+™ Clinical Study in Breast Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2633809051","media":"GlobeNewswire","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633809051?lang=en_us&edition=fundamental","pubTime":"2026-05-06 19:30","pubTimestamp":1778067000,"startTime":"0","endTime":"0","summary":"FDA clearance of Investigational New Drug (IND) application opens path to commence Phase 1/2a clinical study for Bria-BRES+ in metastatic breast cancerBria-BRES+ is BriaCell’s next generation personal","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/05/06/3288700/0/en/BriaCell-Receives-FDA-Clearance-to-Initiate-Bria-BRES-Clinical-Study-in-Breast-Cancer.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LABU","BK4588","BRES","BK4585","BK4086","IND","BCTX","MBC","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630395699","title":"BriaCell Announces Six Clinical Data Presentations at ASCO 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2630395699","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2630395699?lang=en_us&edition=fundamental","pubTime":"2026-04-27 19:30","pubTimestamp":1777289400,"startTime":"0","endTime":"0","summary":"Final randomized Phase 2 Bria-IMT survival and quality of life data to be presentedBiomarker analyses from the ongoing Phase 3 study evaluating predictors of response  PHILADELPHIA and VANCOUVER, Brit","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/04/27/3281510/0/en/BriaCell-Announces-Six-Clinical-Data-Presentations-at-ASCO-2026.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BCTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629036113","title":"BriaCell presents anti-cancer activity of Bria-OTS","url":"https://stock-news.laohu8.com/highlight/detail?id=2629036113","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629036113?lang=en_us&edition=fundamental","pubTime":"2026-04-21 19:54","pubTimestamp":1776772463,"startTime":"0","endTime":"0","summary":"BriaCell (BCTX) Therapeutics is presenting “positive” data from its preclinical Bria-OTS+ platform at the 2026 American Association for Cancer Rese...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/briacell-presents-anti-cancer-activity-of-bria-ots-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/briacell-presents-anti-cancer-activity-of-bria-ots-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","BCTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2628747963","title":"BriaCell Presents Positive Phase 3 Quality of Life and Phase 2 Biomarker Data at the 2026 AACR Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2628747963","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2628747963?lang=en_us&edition=fundamental","pubTime":"2026-04-20 19:30","pubTimestamp":1776684600,"startTime":"0","endTime":"0","summary":"Phase 3 clinical data in heavily pretreated metastatic breast cancer patients with prior failed ADC, CPI, and CDK4/6 inhibitor treatments shows quality of life (QOL) largely preservedIdentification of","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/04/20/3276889/0/en/BriaCell-Presents-Positive-Phase-3-Quality-of-Life-and-Phase-2-Biomarker-Data-at-the-2026-AACR-Meeting.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ADC","BCTX","BK4086","BK4139","BK4080","CPI","BK4231","MBC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624332554","title":"BriaCell Therapeutics Reports Rising Losses and Funding Pressure","url":"https://stock-news.laohu8.com/highlight/detail?id=2624332554","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2624332554?lang=en_us&edition=fundamental","pubTime":"2026-04-01 07:35","pubTimestamp":1775000141,"startTime":"0","endTime":"0","summary":"An announcement from BriaCell Therapeutics ( ($TSE:BCT) ) is now available. On March 31, 2026, BriaPro Therapeutics filed unaudited condensed inter...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/briacell-therapeutics-reports-rising-losses-and-funding-pressure?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/briacell-therapeutics-reports-rising-losses-and-funding-pressure?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BCTX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624537178","title":"BriaCell and BriaPro Announce Closing of Asset Purchase Transaction for Exclusive Soluble CD80 License","url":"https://stock-news.laohu8.com/highlight/detail?id=2624537178","media":"GlobeNewswire","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2624537178?lang=en_us&edition=fundamental","pubTime":"2026-04-01 04:05","pubTimestamp":1774987500,"startTime":"0","endTime":"0","summary":"PHILADELPHIA and VANCOUVER, British Columbia, March  31, 2026 (GLOBE NEWSWIRE) -- BriaCell Therapeutics Corp. (Nasdaq: BCTX, BCTXW, BCTXZ, BCTXL) (TSX: BCT) (“BriaCell”), a clinical-stage biotechnolog","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/03/31/3266014/0/en/BriaCell-and-BriaPro-Announce-Closing-of-Asset-Purchase-Transaction-for-Exclusive-Soluble-CD80-License.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BCTX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620587842","title":"BriaCell to present four posters at the 2026 AACR","url":"https://stock-news.laohu8.com/highlight/detail?id=2620587842","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620587842?lang=en_us&edition=fundamental","pubTime":"2026-03-18 19:42","pubTimestamp":1773834175,"startTime":"0","endTime":"0","summary":"BriaCell (BCTX) Therapeutics announces that it will present four posters at the 2026 American Association for Cancer Research, or AACR, Annual Meet...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/briacell-to-present-four-posters-at-the-2026-aacr-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/briacell-to-present-four-posters-at-the-2026-aacr-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BCTX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620255561","title":"BriaCell to Present Positive Clinical Data for Bria-IMT™ and Preclinical Data for Next Generation Bria-OTS+™ Personalized Immunotherapy at the 2026 AACR Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2620255561","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620255561?lang=en_us&edition=fundamental","pubTime":"2026-03-18 19:30","pubTimestamp":1773833400,"startTime":"0","endTime":"0","summary":"PHILADELPHIA and VANCOUVER, British Columbia, March  18, 2026 (GLOBE NEWSWIRE) -- BriaCell Therapeutics Corp. (Nasdaq: BCTX, BCTXL) (TSX: BCT)(“BriaCell” or the “Company”), a clinical-stage biotechnol","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/03/18/3258061/0/en/BriaCell-to-Present-Positive-Clinical-Data-for-Bria-IMT-and-Preclinical-Data-for-Next-Generation-Bria-OTS-Personalized-Immunotherapy-at-the-2026-AACR-Conference.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BCTX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618930581","title":"BriaCell to Present Four Poster Presentations at the 2026 AACR Annual Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2618930581","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618930581?lang=en_us&edition=fundamental","pubTime":"2026-03-10 19:30","pubTimestamp":1773142200,"startTime":"0","endTime":"0","summary":"PHILADELPHIA and VANCOUVER, British Columbia, March  10, 2026  (GLOBE NEWSWIRE) -- BriaCell Therapeutics Corp. (Nasdaq: BCTX, BCTXL) (TSX: BCT) (“BriaCell” or the “Company”), a clinical-stage biotechn","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/03/10/3252671/0/en/BriaCell-to-Present-Four-Poster-Presentations-at-the-2026-AACR-Annual-Meeting.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BCTX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618677120","title":"BriaCell Shareholders Approve Auditors and Reelect Board","url":"https://stock-news.laohu8.com/highlight/detail?id=2618677120","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618677120?lang=en_us&edition=fundamental","pubTime":"2026-03-10 05:16","pubTimestamp":1773090972,"startTime":"0","endTime":"0","summary":"BriaCell Therapeutics ( ($TSE:BCT) ) has issued an announcement. On March 5, 2026, BriaCell Therapeutics Corp. held its Annual General and Special ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/briacell-shareholders-approve-auditors-and-reelect-board?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/briacell-shareholders-approve-auditors-and-reelect-board?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BCTX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2617711375","title":"BriaCell Shareholders Overwhelmingly Back Board and Auditors at Annual Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2617711375","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2617711375?lang=en_us&edition=fundamental","pubTime":"2026-03-06 05:53","pubTimestamp":1772747582,"startTime":"0","endTime":"0","summary":"The latest announcement is out from BriaCell Therapeutics ( ($TSE:BCT) ). BriaCell Therapeutics reported that 48.31% of its outstanding common shar...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/briacell-shareholders-overwhelmingly-back-board-and-auditors-at-annual-meeting?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/briacell-shareholders-overwhelmingly-back-board-and-auditors-at-annual-meeting?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BCTX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2617576362","title":"BriaCell Therapeutics Corp. Announces Results of Shareholder Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2617576362","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2617576362?lang=en_us&edition=fundamental","pubTime":"2026-03-06 05:04","pubTimestamp":1772744640,"startTime":"0","endTime":"0","summary":"PHILADELPHIA and VANCOUVER, British Columbia, March  05, 2026  (GLOBE NEWSWIRE) -- BriaCell Therapeutics Corp. (Nasdaq: BCTX, BCTXL) (TSX:BCT) (“BriaCell” or the “Company”), a clinical-stage biotechno","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/03/05/3250650/0/en/BriaCell-Therapeutics-Corp-Announces-Results-of-Shareholder-Meeting.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BCTX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2613290458","title":"BriaCell Restructures Soluble CD80 Program via BriaPro Deal","url":"https://stock-news.laohu8.com/highlight/detail?id=2613290458","media":"TIPRANKS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2613290458?lang=en_us&edition=fundamental","pubTime":"2026-02-21 05:47","pubTimestamp":1771624057,"startTime":"0","endTime":"0","summary":"The latest announcement is out from BriaCell Therapeutics ( ($TSE:BCT) ). On February 18, 2026, BriaCell Therapeutics and its majority-owned subsid...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/briacell-restructures-soluble-cd80-program-via-briapro-deal?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/briacell-restructures-soluble-cd80-program-via-briapro-deal?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BCTX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2612427611","title":"BriaPro to purchase BriaCell’s license to develop, commercialize sCD80","url":"https://stock-news.laohu8.com/highlight/detail?id=2612427611","media":"TIPRANKS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2612427611?lang=en_us&edition=fundamental","pubTime":"2026-02-19 06:35","pubTimestamp":1771454125,"startTime":"0","endTime":"0","summary":"BriaCell (BCTX) and its majority-owned subsidiary BriaPro Therapeutics announced that they have entered into a definitive purchase agreement pursua...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/briapro-to-purchase-briacells-license-to-develop-commercialize-scd80-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/briapro-to-purchase-briacells-license-to-develop-commercialize-scd80-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BCTX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2612452720","title":"BriaCell Therapeutics' Phase 3 Breast Cancer Treatment Trial Gets Fifth DSMB Recommendation to Continue","url":"https://stock-news.laohu8.com/highlight/detail?id=2612452720","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2612452720?lang=en_us&edition=fundamental","pubTime":"2026-02-17 21:14","pubTimestamp":1771334096,"startTime":"0","endTime":"0","summary":"BriaCell Therapeutics  said Tuesday an independent data safety monitoring board has recommended for the fifth time continuation of a phase 3 study of its Bria-IMT plus an immune checkpoint inhibitor to treat metastatic breast cancer patients after reviewing safety data.The company said the board, which neets quarterly in accordance with the study protocol, reported no safety concerns and recommended the study continue without modifications.The trial is being conducted under a US Food and Drug Administration 'Fast Track' designation, the company said.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BCTX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2606716058","title":"BriaCell says patient images show regression, resolution of metastsized tumors","url":"https://stock-news.laohu8.com/highlight/detail?id=2606716058","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2606716058?lang=en_us&edition=fundamental","pubTime":"2026-01-28 20:40","pubTimestamp":1769604040,"startTime":"0","endTime":"0","summary":"BriaCell (BCTX) Therapeutics releases new images highlighting resolution of metastatic breast cancer lesions in patients with orbital, temporal lob...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/briacell-says-patient-images-show-regression-resolution-of-metastsized-tumors-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/briacell-says-patient-images-show-regression-resolution-of-metastsized-tumors-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","BCTX"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://briacell.com","stockEarnings":[{"period":"1week","weight":-0.1397},{"period":"1month","weight":-0.2077},{"period":"3month","weight":-0.1203},{"period":"6month","weight":-0.5},{"period":"1year","weight":-0.8903},{"period":"ytd","weight":-0.5063}],"compareEarnings":[{"period":"1week","weight":-0.006},{"period":"1month","weight":0.0332},{"period":"3month","weight":0.0691},{"period":"6month","weight":0.1244},{"period":"1year","weight":0.2335},{"period":"ytd","weight":0.076}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"BriaCell Therapeutics Corp. operates as a Phase 3 biotechnology company transforming cancer care with its novel cellular immunotherapies. It is conducting a pivotal Phase 3 clinical trial in advanced breast cancer with its Bria-IMT in combination with an immune check point inhibitor. It is also developing personalized off-the-shelf treatments for breast cancer, prostate cancer, and other cancers. The company has a collaboration with Incyte Corporation to evaluate combination of the Bria-IMT. BriaCell Therapeutics Corp. is based in West Vancouver, Canada.","yearOnYearQuotes":[{"month":1,"riseRate":0.2,"avgChangeRate":-0.124732},{"month":2,"riseRate":0.2,"avgChangeRate":-0.077389},{"month":3,"riseRate":0.666667,"avgChangeRate":0.07242},{"month":4,"riseRate":0.166667,"avgChangeRate":-0.063453},{"month":5,"riseRate":0,"avgChangeRate":-0.201189},{"month":6,"riseRate":0.6,"avgChangeRate":0.078701},{"month":7,"riseRate":0.4,"avgChangeRate":-0.192928},{"month":8,"riseRate":1,"avgChangeRate":0.139099},{"month":9,"riseRate":0.6,"avgChangeRate":0.155119},{"month":10,"riseRate":0,"avgChangeRate":-0.140813},{"month":11,"riseRate":0.6,"avgChangeRate":0.110284},{"month":12,"riseRate":0.2,"avgChangeRate":-0.186609}],"exchange":"NASDAQ","name":"BriaCell Therapeutics Corp.","nameEN":"BriaCell Therapeutics Corp."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.42.2","shortVersion":"4.42.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"BriaCell Therapeutics Corp.(BCTX),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest BriaCell Therapeutics Corp.(BCTX) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"BriaCell Therapeutics Corp.,BCTX,BriaCell Therapeutics Corp.股票,BriaCell Therapeutics Corp.股票老虎,BriaCell Therapeutics Corp.股票老虎国际,BriaCell Therapeutics Corp.行情,BriaCell Therapeutics Corp.股票行情,BriaCell Therapeutics Corp.股价,BriaCell Therapeutics Corp.股市,BriaCell Therapeutics Corp.股票价格,BriaCell Therapeutics Corp.股票交易,BriaCell Therapeutics Corp.股票购买,BriaCell Therapeutics Corp.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"BriaCell Therapeutics Corp.(BCTX),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest BriaCell Therapeutics Corp.(BCTX) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}